Literature DB >> 27839749

Successful treatment with omalizumab in challenge confirmed exercise-induced anaphylaxis.

Morten J Christensen1, Carsten Bindslev-Jensen2.   

Abstract

Mesh：

Substances：

Year:  2016        PMID： 27839749     DOI： 10.1016/j.jaip.2016.09.035

Source DB:  PubMed          Journal:  J Allergy Clin Immunol Pract


× No keyword cloud information.
  3 in total

Review 1.  Exercise-Induced Anaphylaxis: Literature Review and Recent Updates.

Authors:  Matthew P Giannetti
Journal:  Curr Allergy Asthma Rep       Date:  2018-10-26       Impact factor: 4.806

Review 2.  FcεRI-HDAC3-MCP1 Signaling Axis Promotes Passive Anaphylaxis Mediated by Cellular Interactions.

Authors:  Misun Kim; Yoojung Kwon; Hyun Suk Jung; Youngmi Kim; Dooil Jeoung
Journal:  Int J Mol Sci       Date:  2019-10-08       Impact factor: 5.923

3.  Long-term omalizumab use in the treatment of exercise-induced anaphylaxis.

Authors:  Mark R Peterson; Christopher A Coop
Journal:  Allergy Rhinol (Providence)       Date:  2017-10-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.